Manchester Management Pr, LLC is 10% Owner at FENNEC PHARMACEUTICALS INC. (FENC). They have made 9 open-market trades across 4 companies since 2016, most recently 2025-12-12.
7 open-market purchases totalling $5.5M since 2016, against 2 sales. Across 6 scored buys the stock is down 29.1% at ninety days, and 28.8 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| FENC | 1,586,899 | $15.9M |
| MODD | 3,805,575 | $8.7M |
| SNWV | 63,999 | $320K |
| CLOK | 4,261,000 | — |
| Total | $24.9M |
Shares reported on the most recent Form 4, priced at the 2025-12-15 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 33% | 0% |
| Avg Move | -5.8% | -10.7% | -29.1% |
| Alpha | -4.0% | -9.6% | -28.8% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNWV | SELL | 2025-12-11 | 2025-12-15 | $27.95 | $559K | -1.8% | -9.6% | -28.5% |
| MODD | BUY | 2025-03-20 | 2025-03-24 | $1.92 | $2.3M | -18.2% | -23.4% | -34.3% |
| MODD | BUY | 2024-12-03 | 2024-12-04 | $1.68 | $35K | -11.5% | -16.7% | -57.1% |
| MODD | BUY | 2024-02-16 | 2024-11-25 | $1.10 | $2.0M | -1.7% | -17.4% | -39.8% |
| MODD | BUY | 2020-06-30 | 2021-10-29 | $2.87 | $900K | -31.3% | -10.6% | -10.6% |
| CLOK | BUY | 2019-09-30 | 2019-10-03 | $0.54 | $6K | N/A | N/A | N/A |
| FENC | SELL | 2018-03-16 | 2018-03-29 | $10.10 | $107K | +13.9% | +2.0% | -16.4% |
| FENC | BUY | 2016-08-23 | 2018-03-29 | $2.01 | $96K | +13.9% | +2.0% | -16.4% |
| FENC | BUY | 2016-01-27 | 2018-03-29 | $2.06 | $196K | +13.9% | +2.0% | -16.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.